Causal theory, motor symptoms, non-motor symptoms, diagnosis, and treatment of Parkinson's Disease: a bibliographic review
DOI:
https://doi.org/10.33448/rsd-v11i7.29762Keywords:
Parkinson's disease; Levodopa; Clinical symptoms; Clinical diagnosis; Health Teaching.Abstract
Parkinson's Disease (PD) presents in senescence, limiting movement and progressing to dementia, thus being the second age-related neurodegenerative disease in the world. Thus, this literature review aims to gather relevant information about PD to direct new scientific approaches that will favor the clinical application, and thus, the quality of life of PD patients. Eighty studies published in the last 20 years were selected and analyzed in a database with indexed descriptors. The observed result leads to the understanding of causal theories, motor and non-motor symptoms, diagnosis, and treatment. It was concluded that the study guides, from the information gathered, new experimental studies to improve the quality of life of PD patients.
References
Aarsland, D., Batzu, L., Halliday, G. M., Geurtsen, G. J., Ballard, C., Chaudhuri, K. R. & Weintraub, D. (2021). Parkinson disease-associated cognitive impairment. Nature Reviews Disease Primers, 7, 47. https://doi.org/10.1038/s41572-021-00280-3.
Abreu, G. M., Valença, D. C., Campos, M. Júnior, da Silva, C. P., Pereira, J. S., Araujo , Leite M. A., Rosso, A. L., Nicaretta, D. H., Vasconcellos, L.F., da Silva, D. J., Della Coletta, M. V., Dos Santos, J. M., Gonçalves, A. P., Santos-Rebouças, C. B. & Pimentel, M. M. (2016). Autosomal dominant Parkinson's disease: Incidence of mutations in LRRK2, SNCA, VPS35 and GBA genes in Brazil. Neurosci Lett. 635, 67-70. https://doi.org/10.1016/j.neulet.2016.10.040.
Albers, J. A., Chand, P. & Anch, A. M. (2017). Multifactorial sleep disturbance in Parkinson's disease. Sleep medicine. 35(41), 48. https://doi.org/10.1016/j.sleep.2017.03.026.
Alifirova, V. M., Zhukova, N. G., Zhukova, I. A., Latypova, A. V., Titova, M. A., Mironova, Y. S., Izhboldina, O. P., Nikitina, M. A. & Petrov, V. A. (2016). A role of the gastrointestinal tract microbiota in the pathogenesis of Parkinson's disease. Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova. 116(11),174-179. https://doi.org/10.17116/jnevro2016116111174-179.
Amaro, E. JR. & Yamashita, H. (2001). Aspectos básicos de tomografia Aspectos básicos de tomografia computadorizada e ressonância computadorizada e ressonância, magnética. Rev Bras Psiquiatr. 23(1), 2-3. https://doi.org/10.1590/S1516-44462001000500002.
Barbosa, E. R. & Sallem, F. A. S. (2005). Parkinson´s Disease – Diagnosis. Rev Neurociencias, 13(3), 158-165. https://doi.org/10.34024/rnc.2005.v13.8827.
Beitz, J. M. (2014). Parkinson's disease: a review. Frontiers in bioscience. 6(1), 65-74. https://doi.org/10.2741/s415.
Benadiba, M., Luurtsema, G., Wichert-Ana, L., Buchpigel, C. A. & Filho, G. B. (2012). New molecular targets for PET and SPECT imaging in neurodegenerative diseases. Revista Brasileira de Psiquiatria. 34(2), s125-s148. https://doi.org/10.1016/j.rbp.2012.08.002.
Berg, D., Postuma, R. B., Bloem, B., Chan, P., Dubois, B., Gasser, T., Goetz, C. G., Halliday, G. M., Hardy, J., Lang, A. E., Litvan, I., Marek, K., Obeso, J., Oertel, W., Olanow, C. W., Poewe ,W., Stern, M. & Deuschl, G. (2014). Time to redefine PD? Introductory statement of the MDS Task Force on the definition of Parkinson's disease. Movement disorders: official journal of the Movement Disorder Society. 29(4), 454-62. https://doi.org/10.1002/mds.25844.
Berger, A. (2002). Magnetic resonance imaging. BMJ (Clinical research ed.), 324(7328), 35. https://doi.org/10.1136/bmj.324.7328.35.
Bose, A. & Beal, M. F. (2016). Mitochondria and Parkinson’s disease. J.Neurochem. 139 Suppl. 1, 216–231. https://doi.org/10.1111/jnc.13731.
Braak, H., Del Tredici, K., Rub, U., De Vos, R. A., Jansen Steur, E. N. & Braak, E. (2003). Staging of brain pathology related to sporadic Parkinson's disease. Neurobiology of Aging. 24(2), 197-211. https://doi.org/10.1016/s0197-4580(02)00065-9.
Braak, H., Ghebremedhin, E., Rüb, U., Bratzke, H. & Del Tredici, K. (2004). Stages in the development of Parkinson's disease-related pathology. Cell Tissue Res. 318(1), 121-34. https://doi.org/10.1007/s00441-004-0956-9.
Burré, J., Sharma, M., & Südhof, T. C. (2018). Cell Biology and Pathophysiology of α-Synuclein. Cold Spring Harbor perspectives in medicine, 8(3), a024091. https://doi.org/10.1101/cshperspect.a024091.
Cedikova, M., Pitule, P., Kripnerova, M., Markova, M. & Kuncova, J. (2016). Multiple roles of mitochondria in aging processes. Physiological research. 65(Suppl 5), S519-S531. https://doi.org/10.33549/physiolres.933538.
Chung, S., Lee, E. J., Yun, S., Choe, H. K., Park, S. B., Son, H. J., Kim, K. S., Dluzen, D. E., Lee, I., Hwang, O., Son, G. H. & Kim, K. (2014). Impact of circadian nuclear receptor REV-ERBα on midbrain dopamine production and mood regulation. Cell. 157(4), 858-68. https://doi.org/10.1016/j.cell.2014.03.039.
Deitos, M. V. & Trippo, K. V. (2017). Evaluation of posture image in Parkinson´s disease: A developmental study. Revista Pesquisa Em Fisioterapia, 7(4), 462–469. https://doi.org/10.17267/2238-2704rpf.v7i4.1569.
Díaz-Santos, M., Cao B., Yazdanbakhsh, A., Norton, D. J., Neargarder, S. & Cronin-Golomb, A. (2015). Perceptual, cognitive, and personality rigidity in Parkinson's disease. Neuropsychologia. 69, 183-93. https://doi.org/10.1016/j.neuropsychologia.2015.01.044.
Dirkx, M. F., Zach H., Bloem, B. R., Hallett, M. & Helmich, R. C. (2018). The nature of postural tremor in Parkinson disease. Neurology. 90(13), e1095-e1103. https://doi.org/10.1212/WNL.0000000000005215.
Falup-Pecurariu & Diaconu, Ş. (2017). Sleep Dysfunction in Parkinson's Disease. Int Rev Neurobiol. 133, 719-742. https://doi.org/10.1016/bs.irn.2017.05.033.
Fields, J. A. (2017). Cognitive and Neuropsychiatric Features in Parkinson's and Lewy Body Dementias. Arch Clin Neuropsychol. 32(7), 786-801. https://doi.org/10.1093/arclin/acx085.
Fois, A. F., Briceño, H. M., Fung, V. S. C. (2017). Nonmotor Symptoms in Essential Tremor and Other Tremor Disorders. Int Rev Neurobiol. 134, 1373-1396. https://doi.org/10.1016/bs.irn.2017.05.010.
Foley, J. A., Foltynie, T., Zrinzo, L., Hyam, J. A., Limousin, P., & Cipolotti, L. (2017). Apathy and reduced speed of processing underlie decline in verbal fluency following DBS. Behav. Neurol. 2017, 7348101. https://doi.org/10.1155/2017/7348101.
Frenkel-Toledo, S., Giladi, N., Peretz, C., Herman, T., Gruendlinger, L. & Hausdorff, J. M. (2005). Treadmill walking as an external pacemaker to improve gait rhythm and stability in Parkinson’s disease. Mov Disord, 20(9), 1109-1114. https://doi.org/10.1002/mds.20507.
Fukunaga, J. Y., Quitschal, R. M., Doná, F., Ferraz, H. B., Ganança, M. M. & Caovilla, H. H. (2014). Postural control in Parkinson’s disease. Braz J Otorhinolaryngol. 80(6), 508-14. https://doi.org/10.1016/j.bjorl.2014.05.032.
Gironell, A., Pascual-Sedano, B., Aracil, I., Marín-Lahoz, J., Pagonabarraga, J., & Kulisevsky, J. (2018). Tremor Types in Parkinson Disease: A Descriptive Study Using a New Classification. Parkinson's disease. 2018, 4327597. https://doi.org/10.1155/2018/4327597.
Glover, G. H. (2011). Overview of functional magnetic resonance imaging. Neurosurgery clinics of North America, 22(2), 133–vii. https://doi.org/10.1016/j.nec.2010.11.001.
Gövert F., Becktepe J. & Deuschl G. (2018). The new tremor classification of the International Parkinson and Movement Disorder Society: Update on frequent tremors. Nervenarzt. 89(4), 376-385. https://doi.org/10.1007/s00115-018-0489-1.
Graebner, A. K., Tarsy, D., Shih, L. C., Vanderhorst, V., Kulkarni, O., Kaplan, S. & Simon, D. K. (2017). Clinical Impact of 123I-Ioflupane SPECT (DaTscan) in a Movement Disorder Center. Neurodegenerative diseases. 17(1), 38-43. https://doi.org/10.1159/000447561.
Haehner, A., Hummel, T. & Reichmann, H. (2014). A clinical approach towards smell loss in Parkinson's disease. Journal of Parkinson's disease. 4(2), 189-95. https://doi.org/10.3233/JPD-130278.
Hawkes, C. H., Del Tredici, K. & Braak, H. (2007). Parkinson's disease: a dual-hit hypothesis. Neuropathology and applied neurobiology. 33(6), 599-614. https://doi.org/10.1111/j.1365-2990.2007.00874.x.
Heim, B., Krismer, F., De Marzi, R. & Seppi, K. (2017). Magnetic resonance imaging for the diagnosis of Parkinson's disease. J Neural Transm (Vienna). 124(8), 915-964. https://doi.org/10.1007/s00702-017-1717-8.
Heremans, E., Nackaerts, E., Vervoort, G., Broeder, S., Swinnen, S. P., & Nieuwboer, A. (2016). Impaired Retention of Motor Learning of Writing Skills in Patients with Parkinson's Disease with Freezing of Gait. PloS one, 11(2), e0148933. https://doi.org/10.1371/journal.pone.014893.
Högl, B., Arnulf, I., Comella, C., Ferreira, J., Iranzo, A., Tilley, B., Trenkwalder, C., Poewe, W., Rascol, O., Sampaio, C., Stebbins, G. T., Schrag, A. & Goetz, C. G. (2010). Scales to assess sleep impairment in Parkinson's disease: critique and recommendations. Mov Disord. 25(16), 2704-16. https://doi.org/10.1002/mds.23190.
Janiri, D., Petracca, M., Moccia, L., Tricoli, L., Piano, C., Bove, F., Imbimbo, I., Simonetti, A., Di Nicola, M., Sani, G., Calabresi, P. & Bentivoglio, A. R. (2020). COVID-19 Pandemic and Psychiatric Symptoms: The Impact on Parkinson's Disease in the Elderly. Frontiers in psychiatry, 11, 581144. https://doi.org/10.3389/fpsyt.2020.581144.
Jiao, Z., Zhang, W., Chen, C., Zhu, X., Chen, X., Zhou, M., Peng, G., Liu, H., Qiu, J., Lin, Y., Huang, S., Mo, M., Yang, X., Qu, S. & Xu, P. (2019). Gene Dysfunction Mediates Immune Response to Dopaminergic Degeneration in Parkinson's Disease. ACS Chem Neurosci. 10(2), 803-811. https://doi.org/10.1021/acschemneuro.8b00373.
Jost, W. H. (2017). Autonomic Dysfunction in Parkinson's disease: Cardiovascular Symptoms, Thermoregulation, and Urogenital Symptoms. Int Rev Neurobiol. 134, 771-785. https://doi.org/10.1016/bs.irn.2017.04.003.
Kim, J., Jang, S., Choe, H. K., Chung, S., Son, G. H. & Kim, K. (2017). Implications of Circadian Rhythm in Dopamine and Mood Regulation. Molecules and cells. 40(7), 450-456. https://doi.org/10.14348/molcells.2017.0065.
Kwok, J. Y. Y., Smith, R., Chan, L. M. L., Lam, L. C. C., Fong, D. Y. T., Choi, E. P. H., Lok, K. Y. W., Lee, J. J., Auyeung, M. & Bloem, B. R. (2022). Managing freezing of gait in Parkinson's disease: a systematic review and network meta-analysis. J Neurol, 10.1007/s00415-022-11031-z. Advance online publication. https://doi.org/10.1007/s00415-022-11031-z.
Lee, T. K. & Yankee, E. L. (2021). A review on Parkinson’s disease treatment. Neuroimunol Neuroinflamation, 8, 222. https://doi.org/10.20517/2347-8659.2020.58
Lill, C. M. (2016). Genetics of Parkinson's disease. Molecular and cellular probes, 30(6), 386–396. https://doi.org/10.1016/j.mcp.2016.11.001.
Lima, M. S., Mangilli, L. D., Sassi, F. C. & Andrade, C. R. F. (2015). Functional magnetic resonance and swallowing: critical literature review. Braz J Otorhinolaryngol. 81(6), 671-680. https://doi.org/10.1016/j.bjorl.2015.08.006.
Lopes, M. S., Melo, A. S., Corona, A. P. & Nóbrega, A. C. (2018). Is there auditory impairment in parkinson’s disease? REV. CEFAC. 20(5), 573-582. https://doi.org/ 10.1590/1982-021620182052418.
Lotankar, S., Prabhavalkar, K. S. & Bhatt, L. K. (2017). Biomarkers for Parkinson's Disease: Recent Advancement. Neuroscience bulletin. 33(5), 585-597. https://doi.org/10.1007/s12264-017-0183-5.
Lozano, C. S., Tam, J., & Lozano, A. M. (2018). The changing landscape of surgery for Parkinson’s disease. Mov. Disord. 33(1), 36–47. https://doi.org/10.1002/mds.27228.
Lunati, A., Lesage, S. & Brice, A. (2018). The genetic landscape of Parkinson's disease. Rev Neurol (Paris). 174(9), 628-643. https://doi.org/10.1016/j.neurol.2018.08.004.
Magalhães, F., Rocha, K., Marinho, V., Ribeiro, J., Oliveira, T., Ayres, C., Bento, T., Leite, F., Gupta, D., Bastos, V. H., Velasques, B., Ribeiro, P., Orsini, M. & Teixeira, S. (2018). Neurochemical changes in basal ganglia affect time perception in parkinsonians. Journal of biomedical science. 25(1), 26. https://doi.org/10.1186/s12929-018-0428-2.
McDermott, K. L., Fisher, N., Bradford, S. & Camicioli, R. (2017). Parkinson's disease mild cognitive impairment classifications and neurobehavioral symptoms. Int Psychogeriatr. 30(2), 253-260. https://doi.org/10.1017/S1041610217002265.
McKeith, I. G., Ferman, T. J., Thomas, A. J., Blanc, F., Boeve, B. F., Fujishiro, H., Kantarci, K., Muscio, C., O'Brien, J. T., Postuma, R. B., Aarsland, D., Ballard, C., Bonanni, L., Donaghy, P., Emre, M., Galvin, J. E., Galasko, D., Goldman, J. G., Gomperts, S. N., Honig, L. S., Ikeda, M., Leverenz, J. B., Lewis, S. J. G., Marder, K. S., Masellis, M., Salmon, D. P., Taylor, J. P., Tsuang, D. W., Walker, Z. & Tiraboschi, P. (2020). Diagnostic Study Group. Research criteria for the diagnosis of prodromal dementia with Lewy bodies. Neurology. 94(17), 743-755. https://doi.org/10.1212/WNL.0000000000009323.
Mcnamara, P. (2011). The Cognitive Neuropsychiatry of Parkinson’s Disease. The Massachusetts Institute of Technology Press, 87–109.
Mercuri, N. B. & Bernardi, G. (2005). The 'magic' of L-dopa: why is it the gold standard Parkinson's disease therapy? Trends Pharmacol Sci. 26(7), 341-344. https://doi.org/10.1016/j.tips.2005.05.002.
Mikami, K., Shiraishi, M., Kawasaki, T. & Kamo, T. (2017). Forward flexion of trunk in Parkinson's disease patients is affected by subjective vertical position. Plos One. 12(7), e0181210. https://doi.org/10.1371/journal.pone.0181210.
Ming, W., Palidis, D. J., Spering, M. & Mckeown, M. J. (2016). Visual contrast sensitivity in early-stage Parkinson’s disease. Investigative Ophthalmology & Visual Science. 57, 5696–5704. https://doi.org/10.1167/iovs.16-20025.
Moon, H. E. & Paek, S. H. (2015). Mitochondrial Dysfunction in Parkinson's Disease. Exp Neurobiol. 24(2), 103-16. https://doi.org/10.5607/en.2015.24.2.103.
Mulak, A. & Bonaz, B. (2015). Brain-gut-microbiota axis in Parkinson's disease. World journal of gastroenterology. 21(37), 10609–10620. https://doi.org/10.3748/wjg.v21.i37.10609.
Noyce, A. J., Dickson, J., Rees, R. N., Bestwick, J. P., Isaias, I. U., Politis, M., Giovannoni, G., Warner, T. T., Lees, A. J. & Schrag, A. (2018). Dopamine reuptake transporter-single-photon emission computed tomography and transcranial sonography as imaging markers of prediagnostic Parkinson's disease. Movement Disorders, 33(3), 478-482. https://doi.org/10.1002/mds.27282.
Nuzum, N. D., Loughman, A., Szymlek-Gay, E. A., Teo, W. P., Hendy, A. M. & Macpherson, H. (2022). To the Gut Microbiome and Beyond: The Brain-First or Body-First Hypothesis in Parkinson's Disease. Front Microbiol. 13, 791213. https://doi.org/10.3389/fmicb.2022.791213.
Pfeiffer, R. F. (2020). Autonomic Dysfunction in Parkinson's Disease. Neurotherapeutics. 17(4), 1464-1479. https://doi.org/10.1007/s13311-020-00897-4.
Pikstra, A. R. A., Van Der Hoorn, A., Leenders, K. L. & De Jong, B. M. (2016). Relation of 18-F-Dopa PET with hypokinesia-rigidity, tremor and freezing in Parkinson's disease. NeuroImage Clinical. 11, 68-72. https://doi.org/10.1016/j.nicl.2016.01.010.
Politis, M., Pagano, G. & Niccolini, F. (2017). Imaging in Parkinson's Disease. International review of neurobiology. 132, 233-274. https://doi.org/10.1016/bs.irn.2017.02.015.
Reichmann, H. (2017). Premotor Diagnosis of Parkinson's Disease. Neuroscience bulletin. 33(5), 526-534. https://doi.org/10.1007/s12264-017-0159-5.
Rhodes, C. J. (2017). Magnetic resonance spectroscopy. Science Progress. 241-292. https://doi.org/10.3184/003685017X14993478654307.
Ridder, A., Müller, M. L., Kotagal, V., Frey, K. A., Albin, R. L. & Bohnen, N. I. (2017). Impaired contrast sensitivity is associated with more severe cognitive impairment in Parkinson disease. Parkinsonism & Related disorders. 34, 15-19. https://doi.org/10.1016/j.parkreldis.2016.10.006.
Rodríguez-Violante, M., Zerón-Martínez, R., Cervantes-Arriaga, A. & Corona, T. (2017). Who Can Diagnose Parkinson's Disease First? Role of Pre-motor Symptoms. Arch Med Res. 48(3), 221-227. https://doi.org/10.1016/j.arcmed.2017.08.005.
Seifert, K. D. & Wiener, J. I. (2013). The impact of DaTscan on the diagnosis and management of movement disorders: A retrospective study. American journal of neurodegenerative disease. 2(1), 29–34.
Sharma, M., Naik, V. & Deogaonkar, M. (2016). Emerging applications of deep brain stimulation. J. Neurosurg. Sci. 60(2), 242–255.
Simon, D. K., Tanner, C. M. & Brundin, P. (2020). Parkinson Disease Epidemiology, Pathology, Genetics, and Pathophysiology. Clin Geriatr Med. 36(1), 1-12. https://doi.org/10.1016/j.cger.2019.08.002. https://doi.org/10.1016/j.cger.2019.08.002.
Sousa, A. S., Oliveira, S. O., Alves, L H. (2021). A Pesquisa Bibliográfica: Princípios e Fundamentos. Cadernos da Fucamp, 20(43), 64-83.
Stojkovska, I., Wagner, B. M., & Morrison, B. E. (2015). Parkinson's disease and enhanced inflammatory response. Experimental biology and medicine (Maywood, N.J.), 240(11), 1387–1395. https://doi.org/10.1177/1535370215576313.
Sung, S., Vijiaratnam, N., Chan, D. W. C., Farrell, M. & Evans, A. H. (2018). Parkinson disease: A systemic review of pain sensitivities and its association with clinical pain and response to dopaminergic stimulation. Journal of the neurological sciences. 395, 172-206. https://doi.org/10.1016/j.jns.2018.10.013.
Sveinbjornsdottir, S. (2016). The clinical symptoms of Parkinson's disease. J Neurochem. 139 Suppl 1, 318–324. https://doi.org/10.1111/jnc.13691.
Targa, A. D., Rodrigues, L. S., Noseda, A. C., Aurich, M. F., Andersen, M. L., Tufik, S., da Cunha, C. & Lima, M. M. (2016). Unraveling a new circuitry for sleep regulation in Parkinson's disease. Neuropharmacology. 108, 161-71. https://doi.org/10.1016/j.neuropharm.2016.04.018.
Timpka, J., Fox, T., Fox, K., Honig, H., Odin, P. & Martinez-Martin, P. (2016). Improvement of dyskinesias with L-dopa infusion in advanced Parkinson’s disease. Acta Neurol. Scand. 133, 451–458. https://doi.org/10.1111/ane.12483.
Tokushige, S. I., Terao, Y., Matsuda, S., Furubayashi, T., Sasaki, T., Inomata-Terada S., Yugeta A., Hamada, M., Tsuji, S. & Ugawa, Y. (2018). Does the Clock Tick Slower or Faster in Parkinson's Disease? Insights Gained from the Synchronized Tapping Task. Frontiers in psychology. 11(9), 1178. https://doi.org/10.3389/fpsyg.2018.01178.
Vázquez-Vélez, G. E., & Zoghbi, H. Y. (2021). Parkinson's Disease Genetics and Pathophysiology. Annual review of neuroscience, 44, 87–108. https://doi.org/10.1146/annurev-neuro-100720-034518
Vercruysse, S., Gilat, M., Shine, J. M., Heremans, E., Lewis, S. & Nieuwboer, A. (2014). Freezing beyond gait in Parkinson's disease: a review of current neurobehavioral evidence. Neurosci Biobehav Rev. 43, 213-27. https://doi.org/10.1016/j.neubiorev.2014.04.010.
Wang, G., Xie, H., Hou, S., Chen, W., Zhao, Q. & Li, S. (2015). Development of the 1.2 T~1.5 T Permanent Magnetic Resonance Imaging Device and Its Application for Mouse Imaging. BioMed research international. 2015, 858694. https://doi.org/10.1155/2015/858694.
World Health Organization (WHO) (2022). Mental health and COVID-19: Early evidence of the pandemic’s impact. https://www.who.int/publications/i/item/WHO-2019-nCoV-Sci_Brief-Mental_health-2022.1
Yan, F., Chen, Y., Li, M., Wang, Y., Zhang, W., Chen, X. & Ye, Q. (2018). Gastrointestinal nervous system α-synuclein as a potential biomarker of Parkinson disease. Medicine (Baltimore). 97(28), e11337. https://doi.org/10.1097/MD.0000000000011337.
Yoshii, F., Moriya, Y., Ohnuki, T., Ryo, M. & Takahashi, W. (2016). Postural deformities in Parkinson's disease - Mutual relationships among neck flexion, fore-bent, knee-bent and lateral-bent angles and correlations with clinical predictors. J Clin Mov Disord. 3, 1. https://doi.org/10.1186/s40734-016-0029-8.
Zhou, H., Arias-Ramos, N., López-Larrubia, P., Mason, R. P., Cerdán, S. & Pacheco-Torres, J. (2018). Oxygenation Imaging by Nuclear Magnetic Resonance Methods. Methods in molecular biology. 1718, 297-313. https://doi.org/10.1007/978-1-4939-7531-0_18.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2022 Francisco Magalhães; Valécia Natália Carvalho da Carvalho; Jacks Renan Neves Fernandes; Antonio Thomaz de Oliveira; Thayaná Ribeiro Silva Fernandes ; Silmar Teixeira
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:
1) Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
2) Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
3) Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.
